• A unique collection of 559 microbial metabolites for high throughput screening (HTS) and high content screening (HCS).
• All compounds derived from microbes with better bioavailability.
• A useful tool for microbial metabolites-related drug discovery.
• Bioactivity and safety confirmed by preclinical research and clinical trials. Some compounds have been approved by FDA.
• Structurally diverse, bioactive, and cell permeable.
• More detailed compound information with structure, IC50, and brief introduction.
• High purity and quality validated by NMR and LC/MS.
• All compounds are in stock and continuously updated.